Total Funding
39
93
Total FundingSeries A raised
Growth Score
33 pts
Heat Score
59 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
35145
RareStone Group (Previously Citrine Medicine) deals with healcare services.
DanDan Dong: Co-founderPast Role: Vivo Capital, Managing Director- Rong Chen: Chief Medical OfficerPast Role: Eden Biologics, Chief Medical Officer
About the Company
Citrine Medicine is a rare disease-focused pharmaceutical firm.
Women Founded
